RBR-4c7pd5招募中未知
Comparison of antibody responses to the Gardasil® Quadrivalent Human Papillomavirus Vaccine in HIV-positive men in the Municipality of Campos dos Goytacazes, Rio de Janeiro, Brazil, 2016-2018
Infant Care Serviços medicos LTDA0 个研究点开始时间: 2017年10月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 45Y（—）
- 性别
- Male
入选标准
- •Man with confirmed serological diagnosis of HIV; men aged 18-45 years; men attended at the Center for Infectious and Parasitic Diseases of the Municipal Secretariat of Campos dos Goytacazes; Accept participation in the study; complete the three doses of the quadrivalent HPV vaccine in the dosage regimen offered
排除标准
- •Do not agree to participate in the study; abandonment of research; individuals who do not complete the 3 doses of the vaccine; individuals treated at another infectious disease center
研究者
相似试验
进行中（未招募）
不适用
An Immunogenicity and Safety Study of GARDASIL™ in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 YearsPrevention of HPV types 6, 11, 16 and 18 related cervical cancer, vulvar, vaginal pre-cancers, low-grade, pre-cancerous lesions, and genital warts in Chinese female subjects aged 9 to 45 years and male subjects aged 9 to 15 years.EUCTR2014-004581-16-Outside-EU/EEAMerck Sharp & Dohme (China) Ltd.600
已完成
不适用
Administration of influenza vaccineInfluenza vaccination.need for immunization against influenzaIRCT201009044683N1Shiraz University of Medical Sciences & Health Services110
进行中（未招募）
1 期
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan AfricaVaccination against HPV infection/related diseaseMedDRA version: 19.1Level: LLTClassification code 10071147Term: Human papilloma virus immunizationSystem Organ Class: 100000004865EUCTR2017-000110-35-Outside-EU/EEAMerck & Co., Inc.250
尚未招募
不适用
comparison of immunoglobulin Y and probiotics in reduction of bacterial loadCTRI/2020/06/026249DR SAKSHI JAI
已完成
3 期
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)Healthy Adult Female ParticipantsPreventionPapillomavirus InfectionHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18NCT00090220Merck Sharp & Dohme LLC3,819